XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 99 filers reported holding XERIS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $819,000 | -40.8% | 334,367 | -1.7% | 0.07% | -23.9% |
| Q2 2021 | $1,384,000 | +2.8% | 340,147 | +14.0% | 0.09% | -9.3% |
| Q1 2021 | $1,346,000 | +9.1% | 298,385 | +19.0% | 0.10% | -5.8% |
| Q4 2020 | $1,234,000 | +0.4% | 250,798 | +21.0% | 0.10% | -16.3% |
| Q3 2020 | $1,229,000 | +184.5% | 207,210 | +27.7% | 0.12% | +108.5% |
| Q2 2020 | $432,000 | +63.6% | 162,305 | +20.0% | 0.06% | +55.3% |
| Q1 2020 | $264,000 | -58.7% | 135,255 | +49.2% | 0.04% | -50.0% |
| Q4 2019 | $639,000 | +13.9% | 90,675 | +59.0% | 0.08% | 0.0% |
| Q3 2019 | $561,000 | +19.9% | 57,028 | +39.4% | 0.08% | +11.8% |
| Q2 2019 | $468,000 | +175.3% | 40,914 | +141.8% | 0.07% | +142.9% |
| Q1 2019 | $170,000 | – | 16,920 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sessa Capital IM, L.P. | 4,172,459 | $20,528,000 | 1.31% |
| DELTEC ASSET MANAGEMENT LLC | 693,870 | $3,414,000 | 0.52% |
| Alpine Global Management, LLC | 350,000 | $1,722,000 | 0.35% |
| Redmile Group, LLC | 2,397,441 | $11,795,000 | 0.14% |
| Kamunting Street Capital Management, L.P. | 43,833 | $216,000 | 0.11% |
| IHT Wealth Management, LLC | 250,798 | $1,234,000 | 0.10% |
| SEARLE & CO. | 34,000 | $167,000 | 0.08% |
| GPS Wealth Strategies Group, LLC | 46,025 | $226,000 | 0.08% |
| ArrowMark Colorado Holdings LLC | 1,981,909 | $9,751,000 | 0.08% |
| Gladstone Institutional Advisory LLC | 51,500 | $253 | 0.05% |